Teva Pharmaceutical Industries vs Waters
Teva Pharmaceutical Industries (TEVA), health care, and Waters (WAT), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Waters is worth $88.4B on the stock market and Teva Pharmaceutical Industries $49.7B: Waters is valued at 78% more. Teva Pharmaceutical Industries trades at 99.1 times earnings and Waters at 188; operating margins in their latest fiscal years were 12.5% and 25.4%. Over the past year Teva Pharmaceutical Industries's share price has moved +71.4% and Waters's +20.4%.
Key facts
- Teva Pharmaceutical Industries market value
- $49.7B
- Waters market value
- $88.4B
- Teva Pharmaceutical Industries P/E
- 99.1
- Waters P/E
- 188
- Teva Pharmaceutical Industries revenue
- $17.3BFY to 2025-12-31
- Waters revenue
- $3.2BFY to 2025-12-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | Teva Pharmaceutical Industries | Waters |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $49.7Blower | $88.4Bhigher |
| Revenue | $17.3Bhigher | $3.2Blower |
| Earnings | $1.4Bhigher | $642.6Mlower |
| Employees | 31,173higher | 15,000lower |
| Total assets | $40.7Bhigher | $5.1Blower |
| Valuation | ||
| P/E | 99.1lower | 188higher |
| P/S | 2.9lower | 27.9higher |
| P/B | — | 2.9 |
| Dividend yield | — | 0.00% |
| Profitability | ||
| Operating margin | 12.5%lower | 25.4%higher |
| Balance sheet | ||
| Net assets | $7.9Bhigher | $2.6Blower |
| Total liabilities | $32.8Bhigher | $2.5Blower |
| Total debt | — | $1.4B |
| Cash on hand | $3.6Bhigher | $587.8Mlower |
| Price change | ||
| Today | +0.12%higher | -0.80%lower |
| 1 year | +71.4%higher | +20.4%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
Teva Pharmaceutical Industries only (7)
- Harry Burn4.5%
- Larry Robbins3.4%
- David Einhorn2.5%
- Stanley Druckenmiller0.5%
- Ray Dalio (founder)0.2%
- Rajiv Jain<0.1%
- Cathie Wood<0.1%
Waters only (11)
- Terry Smith7.7%
- Andreas Halvorsen1.8%
- Steven Romick1.4%
- Nicolai Tangen (founder)0.8%
- Brandon Haley0.7%
- Matthew McLennan0.7%
- Jensen team0.5%
- Steve Cohen0.3%
- Israel Englander0.2%
- David Shaw (founder)0.2%
- Bill Nygren<0.1%
Percentages are each holding's share of that investor's reported portfolio. Who owns TEVA · Who owns WAT
More on Teva Pharmaceutical Industries
Further comparisons
Teva Pharmaceutical Industries against its closest peers
Waters against its closest peers
Learn
Questions and answers
Which is bigger, Teva Pharmaceutical Industries or Waters?
By market value, Waters is the larger: $88.4B against $49.7B for Teva Pharmaceutical Industries. By revenue in its latest fiscal year, Teva Pharmaceutical Industries is the larger: $17.3B against $3.2B for Waters.
Which has the higher P/E ratio?
Waters: 188, against 99.1 for Teva Pharmaceutical Industries. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
Waters: 25.4%, against 12.5% for Teva Pharmaceutical Industries. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which superinvestors own both Teva Pharmaceutical Industries and Waters?
None of the tracked superinvestors holds both in their latest 13F filing. 7 hold Teva Pharmaceutical Industries and 11 hold Waters.
Cite this page
Funkfolio, “Teva Pharmaceutical Industries vs Waters”, data as of 17 November 2026. https://funkfolio.com/compare/teva-vs-wat
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.